Neuland Laboratories Limited Share Price & Analysis
₹18,895▼ -0.28%Updated 21 Jul 2026, 05:01 pm IST
LTP
₹18,895
-0.28%
Open
₹—
High
₹19,177
Low
₹18,854
Close
₹18,895
52W High
₹20,089
52W Low
₹11,500
Volume
20K
Lot Size
1
Sector
Healthcare
Market Cap
₹24K Cr
Face Value
₹10
Large CapNIFTY 500SMALLCAP 100
Price Chart
Fundamentals
P/E
65.5
Sector P/E
54.4
P/B
13.39
EPS
₹283.77
ROE
21.2%
ROCE
26.5%
D/E Ratio
0.16
Div Yield
0.18%
Book Value
₹1,461
+
Strengths
- ✓Excellent return on equity (ROE 21.2%)
- ✓Efficient capital deployment (ROCE 26.5%)
- ✓Low debt relative to equity (D/E 0.2x)
−
Concerns
- ✗High premium to book value (P/B 13.4x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
NEULANDLAB · as of Mar 2026
Promoters32.67%
FII22.12%▼1.74
DII10.97%▲1.88
Public33.85%▼0.11
Govt0.40%
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 32.80% | 32.74% | 32.72% | 32.64% | 32.68% | 32.67% |
| FII | 22.69% | 24.43% | 25.72% | 26.46% | 23.86% | 22.12% |
| DII | 6.02% | 6.54% | 6.39% | 6.38% | 9.09% | 10.97% |
| Public | 38.10% | 35.88% | 34.77% | 34.12% | 33.96% | 33.85% |
| Govt | 0.40% | 0.40% | 0.40% | 0.40% | 0.40% | 0.40% |
Corporate Events
Dividend - Rs 34 Per Share
Dividend23 Jul 2026
To consider and approve the financial results for the period ended Jun 30, 2026
Results4 Aug 2026
Dividend - Rs 12 Per Share
Dividend17 Jul 2025
Annual General Meeting/Dividend - Rs 14 Per Share
Dividend11 Jul 2024
Annual General Meeting/Dividend - Rs 10 Per Share
Dividend10 Jul 2023
Latest News
All news →Neuland Labs to hold 42nd AGM, publishes FY25-26 report
*Neuland Labs to hold 42nd AGM, publishes FY25-26 report* — Neuland Laboratories has published a notice for its 42nd Annual General Meeting and the Integrated Annual Report for FY **2025-26**. The report will be dispatched to shareholders shortly. This is a routine corporate compliance filing. 📊 *STOCKS:* NEULANDLAB | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM
NSE Filing10 Jul
Neuland Labs files copy of newspaper publication
*Neuland Labs files copy of newspaper publication.* This is a routine regulatory disclosure with no operational or financial impact. Such filings are part of standard compliance procedures. No immediate action or market-moving information is indicated. 📊 *STOCKS:* NEULANDLAB | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Filing
NSE Filing16 Jun
Financials
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹776 Cr ▲76.4% | ₹440 Cr ▼14.4% | ₹514 Cr ▲75.4% | ₹293 Cr ▼10.7% | ₹328 Cr ▼17.6% | ₹398 Cr ▲28.0% | ₹311 Cr ▼29.3% | ₹440 Cr |
| Op. Profit | ₹307 Cr ▲298.7% | ₹77 Cr ▼50.6% | ₹156 Cr ▲358.8% | ₹34 Cr ▼33.3% | ₹51 Cr ▼41.4% | ₹87 Cr ▲40.3% | ₹62 Cr ▼49.6% | ₹123 Cr |
| OPM | 40.0% ▲122.2% | 18.0% ▼40.0% | 30.0% ▲150.0% | 12.0% ▼25.0% | 16.0% ▼27.3% | 22.0% ▲10.0% | 20.0% ▼28.6% | 28.0% |
| Net Profit | ₹213 Cr ▲419.5% | ₹41 Cr ▼57.7% | ₹97 Cr ▲592.9% | ₹14 Cr ▼50.0% | ₹28 Cr ▼72.5% | ₹102 Cr ▲209.1% | ₹33 Cr ▼66.3% | ₹98 Cr |
| EPS (₹) | 165.76 ▲424.2% | 31.62 ▼58.1% | 75.49 ▲597.0% | 10.83 ▼50.0% | 21.68 ▼72.6% | 79.18 ▲209.3% | 25.6 ▼66.4% | 76.28 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹2.0K Cr ▲37.0% | ₹1.5K Cr ▼5.3% | ₹1.6K Cr ▲30.9% | ₹1.2K Cr ▲25.2% | ₹951 Cr ▲1.5% | ₹937 Cr ▲22.8% | ₹763 Cr ▲14.4% | ₹667 Cr ▲26.6% | ₹527 Cr ▼9.0% | ₹579 Cr |
| Expenses | ₹1.4K Cr ▲25.9% | ₹1.1K Cr ▲4.6% | ₹1.1K Cr ▲19.4% | ₹918 Cr ▲13.8% | ₹807 Cr ▲2.2% | ₹790 Cr ▲19.5% | ₹661 Cr ▲8.7% | ₹608 Cr ▲27.5% | ₹477 Cr ▲1.1% | ₹472 Cr |
| Op. Profit | ₹580 Cr ▲75.2% | ₹331 Cr ▼28.5% | ₹463 Cr ▲69.6% | ₹273 Cr ▲89.6% | ₹144 Cr ▼2.0% | ₹147 Cr ▲44.1% | ₹102 Cr ▲75.9% | ₹58 Cr ▲13.7% | ₹51 Cr ▼51.9% | ₹106 Cr |
| OPM | 29.0% ▲31.8% | 22.0% ▼26.7% | 30.0% ▲30.4% | 23.0% ▲53.3% | 15.0% ▼6.3% | 16.0% ▲23.1% | 13.0% ▲44.4% | 9.0% ▼10.0% | 10.0% ▼44.4% | 18.0% |
| Other Income | ₹25 Cr ▼72.2% | ₹90 Cr ▲650.0% | ₹12 Cr ▲33.3% | ₹9 Cr | ₹0 Cr ▼100.0% | ₹16 Cr ▲300.0% | ₹4 Cr ▲33.3% | ₹3 Cr ▼25.0% | ₹4 Cr ▲300.0% | ₹1 Cr |
| Interest | ₹24 Cr ▲200.0% | ₹8 Cr ▼42.9% | ₹14 Cr ▲7.7% | ₹13 Cr ▼7.1% | ₹14 Cr ▼22.2% | ₹18 Cr ▼18.2% | ₹22 Cr ▲37.5% | ₹16 Cr ▼15.8% | ₹19 Cr ▼9.5% | ₹21 Cr |
| Depreciation | ₹92 Cr ▲39.4% | ₹66 Cr ▲10.0% | ₹60 Cr ▲13.2% | ₹53 Cr ▲8.2% | ₹49 Cr ▲22.5% | ₹40 Cr ▲29.0% | ₹31 Cr ▲19.2% | ₹26 Cr ▲18.2% | ₹22 Cr ▲15.8% | ₹19 Cr |
| PBT | ₹489 Cr ▲41.3% | ₹346 Cr ▼13.7% | ₹401 Cr ▲85.6% | ₹216 Cr ▲163.4% | ₹82 Cr ▼21.9% | ₹105 Cr ▲98.1% | ₹53 Cr ▲165.0% | ₹20 Cr ▲42.9% | ₹14 Cr ▼79.1% | ₹67 Cr |
| Tax % | 26.0% ▲4.0% | 25.0% ▲0.0% | 25.0% ▲4.2% | 24.0% ▲9.1% | 22.0% ▼4.3% | 23.0% ▼66.7% | 69.0% ▲263.2% | 19.0% ▲46.2% | 13.0% ▼56.7% | 30.0% |
| Net Profit | ₹364 Cr ▲40.0% | ₹260 Cr ▼13.3% | ₹300 Cr ▲82.9% | ₹164 Cr ▲156.3% | ₹64 Cr ▼21.0% | ₹81 Cr ▲406.3% | ₹16 Cr ▲0.0% | ₹16 Cr ▲33.3% | ₹12 Cr ▼74.5% | ₹47 Cr |
| EPS (₹) | 283.71 ▲39.9% | 202.74 ▼13.3% | 233.89 ▲83.5% | 127.45 ▲156.2% | 49.74 ▼20.9% | 62.85 ▲397.6% | 12.63 ▼1.4% | 12.81 ▼5.6% | 13.57 ▼74.3% | 52.74 |
| Div Payout | 12.0% ▲100.0% | 6.0% ▲0.0% | 6.0% ▼25.0% | 8.0% ▼20.0% | 10.0% ▲25.0% | 8.0% ▼50.0% | 16.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹13 Cr ▲0.0% | ₹13 Cr ▲0.0% | ₹13 Cr ▲0.0% | ₹13 Cr ▲0.0% | ₹13 Cr ▲0.0% | ₹13 Cr ▲0.0% | ₹13 Cr ▲0.0% | ₹13 Cr ▲44.4% | ₹9 Cr ▲0.0% | ₹9 Cr |
| Reserves | ₹1.9K Cr ▲23.1% | ₹1.5K Cr ▲19.1% | ₹1.3K Cr ▲29.5% | ₹981 Cr ▲18.5% | ₹828 Cr ▲7.0% | ₹774 Cr ▲11.0% | ₹697 Cr ▲1.6% | ₹686 Cr ▲25.0% | ₹549 Cr ▲2.2% | ₹537 Cr |
| Borrowings | ₹301 Cr ▲91.7% | ₹157 Cr ▲65.3% | ₹95 Cr ▼25.8% | ₹128 Cr ▼46.9% | ₹241 Cr ▲32.4% | ₹182 Cr ▼31.1% | ₹264 Cr ▲14.3% | ₹231 Cr ▼27.6% | ₹319 Cr ▲66.1% | ₹192 Cr |
| Other Liabilities | ₹754 Cr ▲51.4% | ₹498 Cr ▲9.7% | ₹454 Cr ▼0.7% | ₹457 Cr ▲51.3% | ₹302 Cr ▼15.2% | ₹356 Cr ▲38.5% | ₹257 Cr ▲28.5% | ₹200 Cr ▲3.1% | ₹194 Cr ▲31.1% | ₹148 Cr |
| Total Liabilities | ₹2.9K Cr ▲34.4% | ₹2.2K Cr ▲18.9% | ₹1.8K Cr ▲16.0% | ₹1.6K Cr ▲14.2% | ₹1.4K Cr ▲4.4% | ₹1.3K Cr ▲7.6% | ₹1.2K Cr ▲8.9% | ₹1.1K Cr ▲5.5% | ₹1.1K Cr ▲20.9% | ₹886 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹1.2K Cr ▲23.2% | ₹955 Cr ▲15.9% | ₹824 Cr ▲8.7% | ₹758 Cr ▼1.2% | ₹767 Cr ▲7.1% | ₹716 Cr ▲9.6% | ₹653 Cr ▲20.5% | ₹542 Cr ▲14.1% | ₹475 Cr ▲1.9% | ₹466 Cr |
| CWIP | ₹211 Cr ▲339.6% | ₹48 Cr ▲4.3% | ₹46 Cr ▲12.2% | ₹41 Cr ▲105.0% | ₹20 Cr ▲17.6% | ₹17 Cr ▼29.2% | ₹24 Cr ▼76.9% | ₹104 Cr ▼17.5% | ₹126 Cr ▲530.0% | ₹20 Cr |
| Investments | ₹2 Cr ▼98.2% | ₹109 Cr ▲10800.0% | ₹1 Cr ▲0.0% | ₹1 Cr ▼75.0% | ₹4 Cr ▼42.9% | ₹7 Cr ▼12.5% | ₹8 Cr ▲0.0% | ₹8 Cr ▲0.0% | ₹8 Cr ▲0.0% | ₹8 Cr |
| Other Assets | ₹1.5K Cr ▲44.3% | ₹1.1K Cr ▲11.0% | ₹962 Cr ▲23.2% | ₹781 Cr ▲31.9% | ₹592 Cr ▲1.2% | ₹585 Cr ▲6.9% | ₹547 Cr ▲14.9% | ₹476 Cr ▲2.8% | ₹463 Cr ▲17.8% | ₹393 Cr |
| Total Assets | ₹2.9K Cr ▲34.4% | ₹2.2K Cr ▲18.9% | ₹1.8K Cr ▲16.0% | ₹1.6K Cr ▲14.2% | ₹1.4K Cr ▲4.4% | ₹1.3K Cr ▲7.6% | ₹1.2K Cr ▲8.9% | ₹1.1K Cr ▲5.5% | ₹1.1K Cr ▲20.9% | ₹886 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹347 Cr ▲9.5% | ₹317 Cr ▲21.5% | ₹261 Cr ▲10.1% | ₹237 Cr ▲295.0% | ₹60 Cr ▼68.3% | ₹189 Cr ▲231.6% | ₹57 Cr ▼18.6% | ₹70 Cr ▲536.4% | ₹11 Cr ▼71.8% | ₹39 Cr |
| Investing CF | ₹-423 Cr ▼41.9% | ₹-298 Cr ▼98.7% | ₹-150 Cr ▼145.9% | ₹-61 Cr ▲35.8% | ₹-95 Cr ▼13.1% | ₹-84 Cr ▼71.4% | ₹-49 Cr ▲36.4% | ₹-77 Cr ▲33.6% | ₹-116 Cr ▼176.2% | ₹-42 Cr |
| Financing CF | ₹21 Cr ▼16.0% | ₹25 Cr ▲136.2% | ₹-69 Cr ▲49.3% | ₹-136 Cr ▼457.9% | ₹38 Cr ▲133.3% | ₹-114 Cr ▼2180.0% | ₹-5 Cr ▼141.7% | ₹12 Cr ▼88.6% | ₹105 Cr | ₹0 Cr |
| Net Cash Flow | ₹-55 Cr ▼225.0% | ₹44 Cr ▲4.8% | ₹42 Cr ▲5.0% | ₹40 Cr ▲1233.3% | ₹3 Cr ▲133.3% | ₹-9 Cr ▼400.0% | ₹3 Cr ▼40.0% | ₹5 Cr | ₹0 Cr ▲100.0% | ₹-4 Cr |
| Free Cash Flow | ₹-50 Cr ▼144.6% | ₹112 Cr ▼5.9% | ₹119 Cr ▼31.2% | ₹173 Cr ▲567.6% | ₹-37 Cr ▼144.0% | ₹84 Cr ▲833.3% | ₹9 Cr ▲28.6% | ₹7 Cr ▲105.8% | ₹-121 Cr ▼5950.0% | ₹-2 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 98d ▲25.6% | 78d ▼10.3% | 87d ▼21.6% | 111d ▲23.3% | 90d ▲5.9% | 85d ▼6.6% | 91d ▲1.1% | 90d ▼32.8% | 134d ▲17.5% | 114d |
| Inventory Days | 245d ▲2.9% | 238d ▲8.2% | 220d ▲4.3% | 211d ▼7.0% | 227d ▲10.7% | 205d ▼1.9% | 209d ▲9.4% | 191d ▼28.2% | 266d ▲43.0% | 186d |
| Days Payable | 129d ▼17.3% | 156d ▲28.9% | 121d ▼6.2% | 129d ▲29.0% | 100d ▼20.6% | 126d ▲14.5% | 110d ▼6.8% | 118d ▼37.6% | 189d ▲60.2% | 118d |
| Cash Conv. Cycle | 214d ▲33.8% | 160d ▼14.4% | 187d ▼3.1% | 193d ▼10.6% | 216d ▲31.7% | 164d ▼13.7% | 190d ▲17.3% | 162d ▼23.2% | 211d ▲15.9% | 182d |
| Working Capital Days | 75d ▼1.3% | 76d ▼13.6% | 88d ▲8.6% | 81d ▲9.5% | 74d ▲23.3% | 60d ▼56.2% | 137d ▼0.7% | 138d ▲263.2% | 38d ▼13.6% | 44d |
| ROCE | 26.0% ▲36.8% | 19.0% ▼42.4% | 33.0% ▲57.1% | 21.0% ▲110.0% | 10.0% ▼9.1% | 11.0% ▲37.5% | 8.0% ▲100.0% | 4.0% ▲0.0% | 4.0% ▼75.0% | 16.0% |
Source: Screener.in · Lower days = better efficiency
Related Analysis
Frequently Asked Questions
What is Neuland Laboratories Limited share price today?▾
Neuland Laboratories Limited (NEULANDLAB) is currently trading at ₹18,895 on NSE, down 0.28% as of the last market session. Prices update daily after market close on MarketNetra.
Is Neuland Laboratories Limited available in F&O (Futures & Options)?▾
Yes, Neuland Laboratories Limited (NEULANDLAB) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Neuland Laboratories Limited 52-week high and low?▾
Neuland Laboratories Limited's 52-week high is ₹20,089 and the 52-week low is ₹11,500. The current price of ₹18,895 is 5.9% below the 52W high.
What is Neuland Laboratories Limited P/E ratio?▾
Neuland Laboratories Limited's current P/E ratio is 65.5. This indicates the market is paying ₹65.5 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Neuland Laboratories Limited options?▾
Neuland Laboratories Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade NEULANDLAB options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.